J. Cox

发表

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

T. Pajak, J. Cox, J. Stetz, 1995, International journal of radiation oncology, biology, physics.

Clinical course of solitary extramedullary plasmacytoma.

J. Cox, D. Weber, C. Ha, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.

J. Cox, D. Weber, C. Ha, 1998, International journal of radiation oncology, biology, physics.

TGFβ1 Polymorphisms Predict Distant Metastasis–Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy

Q. Wei, R. Komaki, Z. Liao, 2013, PloS one.

Predictors of postoperative complications after trimodality therapy for esophageal cancer.

J. Ajani, S. Swisher, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

Proton beam therapy and concurrent chemotherapy for esophageal cancer.

R. Mohan, J. Ajani, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.

K. Forster, J. Roth, R. Herbst, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Should randomized clinical trials be required for proton radiotherapy?

J. Cox, James D Cox, M. Goitein, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radioprotectors and Chemoprotectors in the Management of Lung Cancer

R. Komaki, Z. Liao, J. Cox, 2011 .

Novel approaches to locally advanced unresectable non-small cell lung cancer.

C. Stevens, R. Komaki, J. Cox, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Consensus statement: Guidelines for PSA following radiation therapy

James D. Cox, David J. Grignon, James T. Parsons, 1997 .

Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck.

David J. Yang, L. Broemeling, R. Wendt, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Patients with Squamous Cell Carcinoma of the Head and Neck

L. Broemeling, R. Wendt, D. Podoloff, 2004 .

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

P. Rubin, S. Doggett, W. Sause, 1991, International journal of radiation oncology, biology, physics.

Estimation of α/β for late rectal toxicity based on RTOG 94-06.

R. Mohan, J. Purdy, W. Bosch, 2011, International journal of radiation oncology, biology, physics.

Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.

P. Mclaughlin, J. Cox, F. Cabanillas, 1998, Blood.

Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.

A. Markoe, H. Sandler, K. Bae, 2010, International journal of radiation oncology, biology, physics.

Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.

Jeff M Michalski, Mack Roach, James A Purdy, 2005, International journal of radiation oncology, biology, physics.

Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.

Richard K Valicenti, Jeff M Michalski, Mack Roach, 2004, International journal of radiation oncology, biology, physics.

Limited-stage small-cell lung cancer: patient survival after combined chemotherapy and radiation therapy with and without treatment protocols.

J. Cox, P. Perkins, P. Allen, 1995, Radiology.

Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.

W. Hong, R. Herbst, R. Komaki, 2009, International journal of radiation oncology, biology, physics.

Causes of treatment failure and death in carcinoma of the lung.

J. Cox, R. Yesner, J. Cox, 1981, The Yale journal of biology and medicine.

Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment.

W. Woodward, M. Andreeff, J. Cox, 2007, Cancer research.

Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report.

J. Cox, A. Hartz, R. Byhardt, 1987, Archives of otolaryngology--head & neck surgery.

Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.

D. Gomez, J. Welsh, Steven H. Lin, 2017, International journal of radiation oncology, biology, physics.

Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Benjamin Movsas, Walter J Curran, Elizabeth Gore, 2011, Journal of the National Cancer Institute.

Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.

M. McAleer, R. Komaki, W. Sause, 2010, International journal of radiation oncology, biology, physics.

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.

W. Curran, W. Sause, B. Emami, 1997, International journal of radiation oncology, biology, physics.

The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.

M. Graham, C. Perez, B. Emami, 2003, Lung cancer.

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel.

P. Schellhammer, R. Kaplan, E. Hammond, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406.

A. Markoe, H. Sandler, J. Purdy, 2004, International journal of radiation oncology, biology, physics.

Does hormone therapy reduce disease recurrence in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of Radiation Therapy Oncology Group 94-06.

H. Sandler, R. Valicenti, J. Michalski, 2011, International journal of radiation oncology, biology, physics.

The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience.

P. Rubin, W. Sause, C. Perez, 1991, International journal of radiation oncology, biology, physics.

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.

Radhe Mohan, Joe Y. Chang, Xiaoning Pan, 2010, International journal of radiation oncology, biology, physics.

Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiation therapy.

Laurence Court, Lei Dong, Yongbin Zhang, 2013, Practical radiation oncology.

Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiotherapy.

Laurence Court, Lei Dong, Yongbin Zhang, 2013, Practical radiation oncology.

Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation.

A S Garden, C A Meyers, A. Garden, 1995, International journal of radiation oncology, biology, physics.

Cranial irradiation in cancer of the lung of all cell types.

Z. Petrovich, J. Cox, R. Yesner, 1981, JAMA.

Influence of preoperative irradiation on failures of endometrial carcinoma with high risk of lymph node metastasis

J. Cox, R. Komaki, A. Hartz, 1984, American journal of clinical oncology.

Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Final Results of a Phase 2 Study

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017, JAMA oncology.

Bayesian randomized trial comparing intensity modulated radiation therapy versus passively scattered proton therapy for locally advanced non-small cell lung cancer.

Radhe Mohan, Daniel Gomez, James D. Cox, 2016 .

Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer

Joe Y. Chang, R. Komaki, Z. Liao, 2011, Cancer.

Role of radiation therapy in small cell anaplastic carcinoma of the lung.

R. Wittes, P. Bunn, N. Bleehen, 1983, Cancer treatment reports.

Is chest radiotherapy necessary in any or all patients with small cell carcinoma of the lung? Yes.

J. Cox, R. Byhardt, J. Cox, 1983, Cancer treatment reports.

Localized primary malignant lymphoma of bone.

J. Murray, L. Fuller, J. Cox, 1997, International journal of radiation oncology, biology, physics.

Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.

R. Herbst, C. Stevens, R. Komaki, 2004, International journal of radiation oncology, biology, physics.

Prognostic Value of Positron Emission Tomography/Computed Tomography Findings in Limited-stage Small Cell Lung Cancer Before Chemoradiation Therapy

G. Gladish, D. Gomez, R. Komaki, 2014, American journal of clinical oncology.

Molecular Basis of Radiation Therapy

W. Woodward, J. Cox, J. Cox, 2008 .

Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer.

George Starkschall, Karl Prado, Tinsu Pan, 2007, International journal of radiation oncology, biology, physics.

The risk of developing a second cancer after receiving craniospinal proton irradiation

R. Mohan, J. Cox, M. Stovall, 2009, Physics in medicine and biology.

Paternalism, informed consent and Tuskegee.

J. Cox, J. Cox, 1998, International journal of radiation oncology, biology, physics.

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials.

D. Grignon, W. Shipley, J. Cox, 2000, International journal of radiation oncology, biology, physics.

Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.

Terry L. Smith, L. Fuller, P. Mclaughlin, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term results with radiotherapy for Stage I-II follicular lymphomas.

S. Tucker, L. Fuller, P. Mclaughlin, 2001, International journal of radiation oncology, biology, physics.

The role of local radiation therapy for mediastinal disease in adults with T‐cell lymphoblastic lymphoma

H. Kantarjian, J. Cortes, J. Cox, 2002, Cancer.

Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.

R. Mohan, J. Purdy, W. Bosch, 2012, International journal of radiation oncology, biology, physics.

Radiotherapy in the management of locally advanced lung cancer of all cell types: Final report of randomized trial

Z. Petrovich, J. Cox, K. Stanley, 1981, Cancer.

Design and Implementation of Clinical Trials of Ion Beam Therapy

J. Cox, J. Cox, 2012 .

NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.

D. Ettinger, M. Kris, R. Ginsberg, 1996, Oncology.

Non-small cell lung cancer. Role of radiation therapy.

J. Cox, J. Cox, 1986, Chest.

The role of radiation therapy for carcinoma of the lung.

J. Cox, J. Cox, 1981, The Yale journal of biology and medicine.

Non-small Cell Lung Cancer* Role of RadiationTherapy

J. Cox, J. Cox, 2017 .

New frontiers in the treatment of lung cancer.

D. Ettinger, E. Zinreich, J. Cox, 1985, Critical reviews in oncology/hematology.

Carcinoid tumors of the lung and family history of cancer.

J. Cox, P. Perkins, B. Kemp, 1997, Journal of clinical epidemiology.

Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment.

Radhe Mohan, Lei Dong, Wayne D Newhauser, 2007, International journal of radiation oncology, biology, physics.

Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.

Radhe Mohan, Lei Dong, Renaud de Crevoisier, 2005, International journal of radiation oncology, biology, physics.

Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy.

Radhe Mohan, Lei Dong, He Wang, 2004, International journal of radiation oncology, biology, physics.

Dose escalation by proton irradiation for adenocarcinoma of the prostate.

J. Cox, 1995, International journal of radiation oncology, biology, physics.

Radiotherapy for lung cancer.

N. Bleehen, J. Cox, J. Cox, 1985, International journal of radiation oncology, biology, physics.

Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography.

George Starkschall, Tinsu Pan, Radhe Mohan, 2007, International journal of radiation oncology, biology, physics.

Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.

Thomas Guerrero, Radhe Mohan, T. Guerrero, 2005, International journal of radiation oncology, biology, physics.

International prognostic index‐based outcomes for diffuse large B‐cell lymphomas

S. Tucker, F. Cabanillas, L. Medeiros, 2002, Cancer.

A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer

Joe Y. Chang, T. Guerrero, R. Komaki, 2005, Clinical Cancer Research.

Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer.

Joe Y. Chang, R. Mohan, Helen H Liu, 2009, International journal of radiation oncology, biology, physics.

The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.

J. Manning, J. Cox, F. Cabanillas, 2000, International journal of radiation oncology, biology, physics.

Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies.

J. Cox, F. Cabanillas, C. Ha, 1999, Radiology.

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.

W. Curran, R. Livingston, W. Sause, 1995, Journal of the National Cancer Institute.

Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review.

R. Komaki, J. Erasmus, J. Cox, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

J. Ajani, J. Roth, S. Swisher, 2004, International journal of radiation oncology, biology, physics.

Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.

J. Cox, F. Cabanillas, A. Younes, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma

J. Ajani, J. Roth, S. Swisher, 2004, Cancer.

Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases.

E. Mendel, L. Rhines, A. Shiu, 2004, International journal of radiation oncology, biology, physics.

Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.

C. Pelloski, J. Cox, F. Cabanillas, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.

M. Martel, Li-E. Wang, Q. Wei, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation therapy for malignant lymphoma: enduring importance in the era of systemic therapy.

J. Cox, R. Wilder, C. Ha, 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.

S. Tucker, J. Cox, F. Cabanillas, 2000, International journal of radiation oncology, biology, physics.

Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.

P. Mclaughlin, J. Cox, F. Cabanillas, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).

S. Tucker, P. Mclaughlin, J. Cox, 2001, International journal of radiation oncology, biology, physics.

Early Results of Stereotactic Body Radiation Therapy (SBRT) in Centrally/Superiorly Located Stage I or Isolated Recurrent NSCLC

P. Balter, M. McAleer, M. Bucci, 2008 .

Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.

R. Mohan, M. Martel, D. Gomez, 2012, International journal of radiation oncology, biology, physics.

Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer.

G. Starkschall, C. Stevens, R. Komaki, 2003, International journal of radiation oncology, biology, physics.

Thymoma: treatment and prognosis.

R. Komaki, J. Cox, A. Pollack, 1992, International journal of radiation oncology, biology, physics.

A Multidisciplinary Approach to Therapy for Unresectable Malignant Thymoma

W. Hong, J. Roth, J. Nesbitt, 1998, Annals of Internal Medicine.

Cure and follicular lymphoma.

J. Cox, J. Cox, 1997, International journal of radiation oncology, biology, physics.

Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.

Joe Y. Chang, T. Guerrero, R. Herbst, 2007, International journal of radiation oncology, biology, physics.

Standards for diagnosis and management of invasive breast carcinoma

D. Winchester, J. Cox, J. Cox, 1998, CA: a cancer journal for clinicians.

Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma.

J. Cox, P. Allen, Jing Li, 2011, International journal of radiation oncology, biology, physics.

Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma

F. Cabanillas, J. Cox, R. Wilder, 2001, Cancer.

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials.

T. Pajak, B. Emami, J. Cox, 1993, International journal of radiation oncology, biology, physics.

interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts new evidence for accelerated proliferation from radiation therapy oncology group protocol 8313

P. Rubin, T. Pajak, K. Fu, 1992, Cancer.

Complications of radiation therapy and factors in their prevention

J. Cox, R. Komaki, R. Byhardt, 1986, World Journal of Surgery.

Large‐dose fractionation. (Hypofractionation)

J. Cox, J. Cox, 1985, Cancer.

Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance.

Peter A Balter, Ritsuko Komaki, Rudy Guerra, 2007, International journal of radiation oncology, biology, physics.

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.

J. Jacobs, T. Pajak, J. Cooper, 1996, International journal of radiation oncology, biology, physics.

The radiation therapy oncology group: An update of clinical research activities

T. Pajak, T. Phillips, S. Leibel, 1991 .

Brain metastasis in patients with superior sulcus tumors

J. Cox, A. Hartz, R. Byhardt, 1987, Cancer.

What is the lowest effective biologic dose for prophylactic cranial irradiation?

J. Cox, R. Komaki, R. Byhardt, 1985, American journal of clinical oncology.

Superior sulcus tumors: Results of irradiation of 36 patients

J. Cox, R. Komaki, James Roh, 1981, Cancer.

Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy

J. Manning, F. Cabanillas, J. Cox, 2001, Cancer.

Weekly localization films and detection of field placement errors.

J. Cox, R. Byhardt, A. Hornburg, 1978, International journal of radiation oncology, biology, physics.

Total body irradiation vs. chemotherapy as a systemic adjuvant for small cell carcinoma of the lung.

J. Cox, R. Byhardt, J. Wilson, 1979, International journal of radiation oncology, biology, physics.

Clinical research on the treatment of locally advanced lung cancer. Final report of VALG protocol 13 limited

Z. Petrovich, J. Cox, M. Ohanian, 1978, Cancer.

Prophylactic cranial irradiation in patients with inoperable carcinoma of the lung. Preliminary report of a cooperative trial

Z. Petrovich, J. Cox, K. Stanley, 1977, Cancer.

Clinical report on the treatment of locally advanced lung cancer

Z. Petrovich, J. Cox, W. Mietlowski, 1977 .

Total central lymphatic irradiation for stage III nodular malignant lymphoreticular tumors.

J. Cox, J. Cox, 1976, International journal of radiation oncology, biology, physics.

Radiotherapeutic management of complications of carcinoma of the lung.

J. Cox, J. Cox, 1982, Clinics in chest medicine.

Patterns of failure in patients with inoperable carcinoma of the lung

Z. Petrovich, J. Cox, K. Stanley, 1981, Cancer.

Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group.

J. Cox, R. Yesner, J. Cox, 1979, The American review of respiratory disease.

Definition and Management of Superior Sulcus Tumors

J. Erasmus, J. Cox, R. Mehran, 2018, Archives of Oncology and Cancer Therapy.

THE MANAGEMENT OF SUPERIOR SULCUS TUMORS

W. Hong, J. Roth, C. Stevens, 2001 .

The respective roles of radiation therapy and chemotherapy in non-small cell carcinoma of the lung with mediastinal but not distant metastasis (N2M0)

J. Cox, 1991 .

Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy.

Radhe Mohan, Ehud Mendel, Laurence D Rhines, 2003, International journal of radiation oncology, biology, physics.

Cardiac localization of 99mTc-(Sn)-pyrophosphate following irradiation of the chest.

J. Cox, H. Swartz, J. Soin, 1977, Radiology.

A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract.

R. Hoffmann, J. Cox, P. Ritch, 1986, International journal of radiation oncology, biology, physics.

Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.

P. Rubin, T. Pajak, J. Cooper, 1989, International journal of radiation oncology, biology, physics.

Irradiation of stage I and II Hodgkin's disease.

J. Cox, J. Fazekas, W. Turner, 1975, The American journal of roentgenology, radium therapy, and nuclear medicine.

Agreement rates among single photon emission computed tomography using gallium‐67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome

J. Cox, P. Allen, E. Kim, 2000, Cancer.

Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer.

Radhe Mohan, Joe Y. Chang, Zhongxing Liao, 2013, Medical Dosimetry.

Prevention of Diagnostic and Treatment-Related Sequelae in Stage I and II Hodgkin´s Disease

J. Cox, C. Ha, J. Cox, 1999 .

Characteristics of long‐term survivors after treatment for inoperable carcinoma of the lung

Hongyung Choi, J. Cox, R. Komaki, 1985, American journal of clinical oncology.

Prospective Exploratory Analysis of Cardiac Biomarkers and Electrocardiogram Abnormalities in Patients Receiving Thoracic Radiation Therapy with High-Dose Heart Exposure

Joe Y. Chang, D. Gomez, J. Welsh, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Locally advanced adenocarcinoma of the endometrium: Results of irradiation with and without subsequent hysterectomy

J. Cox, J. Wilson, M. Greenberg, 1978, Cancer.

Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group.

P. Rubin, W. Sause, J. Cox, 1988, International journal of radiation oncology, biology, physics.

Concomitant adjuvant chemotherapy and radiotherapy for high risk breast cancer patients

B. Erickson, J. Cox, N. Janjan, 2005, Breast Cancer Research and Treatment.

Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung

Z. Petrovich, J. Cox, W. Mietlowski, 1979, Cancer.

Irradiation for bronchial carcinoma: Reasons for failure. I. Analysis of local control as a function of dose, time, and fractionation

J. Cox, R. Komaki, D. Eisert, 1976, Cancer.

Primary parotid lymphoma: the effect of International Prognostic Index on outcome.

P. Mclaughlin, J. Cox, F. Cabanillas, 1997, Leukemia & lymphoma.

Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).

L. Fuller, J. Cox, M. Meistrich, 2000, International journal of radiation oncology, biology, physics.

The role of consolidation irradiation in combined modality therapy of small cell carcinoma of the lung.

J. Cox, R. Byhardt, P. Holoye, 1981, International journal of radiation oncology, biology, physics.

Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small‐cell carcinoma of the lung

J. Cox, R. Komaki, R. Byhardt, 1981, Cancer.

Phase I-II study of prophylactic hepatic irradiation with local irradiation and systemic chemotherapy for adenocarcinoma of the pancreas.

J. Cox, R. Komaki, J. Wilson, 1988, International journal of radiation oncology, biology, physics.

Thymoma. A retrospective study of 87 cases

J. Cox, A. Pollack, J. Putnam, 1994, Cancer.

The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies

R. Hoffmann, J. Cox, P. Ritch, 1987, The Laryngoscope.

Second Malignancies After Chemotherapy and Radiotherapy for Hodgkin Disease

Maria A. Rodriguez, L. Levy, E. Atkinson, 2004, American journal of clinical oncology.

Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.

S. Tucker, P. Mclaughlin, J. Cox, 2001, International journal of radiation oncology, biology, physics.

High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma.

L. Fuller, F. Cabanillas, J. Cox, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma

J. Cox, F. Cabanillas, B. Andersson, 2004, Bone Marrow Transplantation.

Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.

R. Mohan, M. Martel, R. Komaki, 2010, International journal of radiation oncology, biology, physics.

Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.

R. Mohan, M. Martel, R. Komaki, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Association between Systemic Chemotherapy before Chemoradiation and Increased Risk of Treatment-Related Pneumonitis in Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy

R. Mohan, J. Ajani, S. Swisher, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Radhe Mohan, Zhongxing Liao, Sue S Yom, 2007, International journal of radiation oncology, biology, physics.

Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).

Zhongxing Liao, Xiong Wei, Helen H Liu, 2005, International journal of radiation oncology, biology, physics.

Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer.

P. Thall, M. Mehta, M. Suntharalingam, 2017, Radiotherapy and Oncology.

Comparing Proton Beam to Intensity Modulated Radiation Therapy Planning in Esophageal Cancer

Steven H. Lin, Z. Liao, J. Cox, 2015 .

Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.

P. Thall, J. Ajani, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer.

Radhe Mohan, Zhongxing Liao, Wayne D Newhauser, 2008, International journal of radiation oncology, biology, physics.

Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

Helen H Liu, J. Ajani, S. Swisher, 2006, International journal of radiation oncology, biology, physics.

Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.

Joe Y. Chang, A. Garg, T. Guerrero, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Incidence of Second Malignancy after Successful Treatment of Limited‐Stage Small–Cell Lung Cancer and Its Effects on Survival

J. Welsh, Steven H. Lin, R. Komaki, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

102 The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non-small cell lung cancer: An RTOG analysis

M. Graham, C. Perez, B. Emami, 1996 .

Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation.

Joe Y. Chang, P. Balter, M. Bucci, 2007, International journal of radiation oncology, biology, physics.

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

Joe Y. Chang, Zhongxing Liao, James D. Cox, 2011, Front. Oncol..

APhase IClinicalTrial ofThoracic Radiotherapy and Concurrent Celecoxib for Patientswith Unfavorable Performance Status Inoperable/Unresectable Non^Small Cell Lung Cancer

Joe Y. Chang, Z. Liao, J. Cox, 2005 .

IClinicalTrial ofThoracic Radiotherapy and Concurrent Celecoxib for Patientswith Unfavorable Performance Status Inoperable / Unresectable Non ^ Small Cell Lung Cancer

Joe Y. Chang, T. Guerrero, R. Komaki, 2005 .

Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.

J. Purdy, M. Roach, W. Bosch, 2004, International journal of radiation oncology, biology, physics.

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.

D. Grignon, R. Abrams, F. Sarkar, 1997, Journal of the National Cancer Institute.

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).

A. Markoe, J. Earle, H. Sandler, 2002, International journal of radiation oncology, biology, physics.

Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer?

Joe Y. Chang, S. McGovern, M. McAleer, 2009, Cancer.

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.

W. Sause, J. Cox, R. Komaki, 2000, International journal of radiation oncology, biology, physics.

Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.

Radhe Mohan, Joe Y. Chang, Daniel Gomez, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting.

Heng Li, Li Liao, Joe Y. Chang, 2014, Practical radiation oncology.

On the interplay effects with proton scanning beams in stage III lung cancer.

Heng Li, Li Liao, Joe Y. Chang, 2014, Medical physics.

The M. D. Anderson proton therapy system.

Radhe Mohan, Kazuo Hiramoto, Martin Bues, 2009, Medical physics.

Individualized Radiotherapy by Dose Escalation and Altered Fractionation in Non‐Small Cell Lung Cancer

Joe Y. Chang, R. Komaki, J. Cox, 2014 .

Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.

Radhe Mohan, Lei Dong, Zhongxing Liao, 2004, International journal of radiation oncology, biology, physics.

Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer.

C. Stevens, R. Komaki, Z. Liao, 2002, International journal of radiation oncology, biology, physics.

Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.

R. Komaki, B. Emami, J. Cox, 1997, American journal of clinical oncology.

A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls

T. Buchholz, A. Sigurdson, J. Cox, 2004, Cancer.

Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer.

Jinzhong Yang, J. Welsh, R. Komaki, 2011, International journal of radiation oncology, biology, physics.

Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies.

T. Pajak, W. Sause, C. Perez, 1994, Lung cancer.

Induction or Concurrent Chemotherapy and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

R. Komaki, J. Cox, J. Cox, 1999 .

ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313.

P. Rubin, T. Pajak, K. Fu, 1991, International journal of radiation oncology, biology, physics.

Esophageal cancer dose escalation using a simultaneous integrated boost technique.

J. Ajani, D. Gomez, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma.

Joe Y. Chang, J. Ajani, S. Swisher, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Localized primary non-Hodgkin lymphoma of the breast.

J. Cox, F. Cabanillas, C. Ha, 1998, American journal of clinical oncology.

An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease

S. Tucker, J. Cox, F. Cabanillas, 2002, Cancer.

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.

L. Gaspar, K. Fu, B. Emami, 1997, International journal of radiation oncology, biology, physics.

Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.

Z. Liao, S. Tucker, L. Fuller, 1998, International journal of radiation oncology, biology, physics.

Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer.

Joe Y. Chang, D. Gomez, R. Komaki, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

lLong-Term Outcomes after Proton Therapy, with Concurrent Chemotherapy, for Stage II-III Inoperable Non-Small Cell Lung Cancer

Joe Y. Chang, Z. Liao, L. Levy, 2016 .

Radiochemotherapy of esophageal cancer.

Z. Liao, J. Cox, R. Komaki, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Status of particle therapy for lung cancer

Steven H. Lin, Z. Liao, J. Cox, 2011, Acta oncologica.

Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma.

L. North, J. Cox, F. Cabanillas, 1998, International journal of radiation oncology, biology, physics.

The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies.

W. Sause, B. Movsas, J. Cox, 1999, International journal of radiation oncology, biology, physics.

Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, Stage III, predict long-term survival?

J. Cox, R. Kline, J. Cox, 1981, International journal of radiation oncology, biology, physics.

Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer

Joe Y. Chang, M. Spitz, J. Minna, 2010, PloS one.

Improving radiation conformality in the treatment of non-small cell lung cancer.

Joe Y. Chang, J. Cox, J. Cox, 2010, Seminars in radiation oncology.

Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer.

George Starkschall, Radhe Mohan, Joe Y. Chang, 2008, International journal of radiation oncology, biology, physics.

Dose-time relationships and the local control of small cell carcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1978, Radiology.

Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.

R. Mohan, R. Komaki, Z. Liao, 2008, International journal of radiation oncology, biology, physics.

Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)".

S. Lippman, J. Roth, S. Swisher, 2008, Chest.

Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.

Radhe Mohan, Joe Y. Chang, Yixiu Kang, 2006, International journal of radiation oncology, biology, physics.

Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.

R. Mohan, J. Ajani, J. Roth, 2003, International journal of radiation oncology, biology, physics.

A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report.

R. Komaki, J. Cox, F. Fossella, 1998, International journal of radiation oncology, biology, physics.

Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410)

W. Curran, R. Komaki, S. Hauser, 2000 .

Frequency of brain metastasis in adenocarcinoma and large cell carcinoma of the lung: correlation with survival.

J. Cox, R. Komaki, R. Stark, 1983, International journal of radiation oncology, biology, physics.

Validation of a model-based segmentation approach to propagating normal anatomic regions of interest through the 10 phases of respiration.

R. Mohan, G. Starkschall, R. Komaki, 2008, International journal of radiation oncology, biology, physics.

Brachytherapy in Lung Cancer

J. Cox, B. Hilaris, J. Cox, 1986 .

Brachytherapyin Lung Cancer

J. Cox, B. Hilaris, J. Cox, 2017 .

SUV by FDG-PET predicts outcome of non-small cell lung cancer

K. Forster, J. Roth, R. Komaki, 2003 .

Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.

He Wang, J. O'Daniel, R. Mohan, 2006, International journal of radiation oncology, biology, physics.

Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.

W. Hong, J. Roth, T. McDonnell, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.

W. Hong, J. Roth, T. McDonnell, 2002, International journal of radiation oncology, biology, physics.

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials

R. Komaki, L. Gaspar, K. Fu, 1999 .

Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.

J. Ajani, J. Roth, S. Swisher, 2003, International journal of radiation oncology, biology, physics.

Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer.

Helen H Liu, J. Ajani, S. Swisher, 2006, World journal of gastroenterology.

Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience

Joe Y. Chang, T. Guerrero, J. Ajani, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?

H. Sandler, J. Purdy, R. Valicenti, 2003, International journal of radiation oncology, biology, physics.

Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.

Thomas Guerrero, Radhe Mohan, Joe Y. Chang, 2004, International journal of radiation oncology, biology, physics.

Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.

Radhe Mohan, Edward S. Kim, Xiong Wei, 2010, International journal of radiation oncology, biology, physics.

Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.

R. Mohan, A. Garden, R. Weber, 2014, International journal of radiation oncology, biology, physics.

Lymphoma of the nasal cavity and paranasal sinuses

J. Cox, V. Kavadi, C. Ha, 1997, Cancer.

Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis

J. Welsh, Steven H. Lin, R. Komaki, 2018, Radiation oncology.

Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer.

R. Mohan, Steven H. Lin, G. Starkschall, 2012, International journal of radiation oncology, biology, physics.

Image-guided radiation therapy for non-small cell lung cancer.

George Starkschall, Peter Balter, Radhe Mohan, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.

R. Mohan, M. Martel, P. Balter, 2012, International journal of radiation oncology, biology, physics.

Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.

R. Mohan, R. Komaki, Z. Liao, 2006, International journal of radiation oncology, biology, physics.

2463: Intra-Thoracic Patterns of Failure for Non-Small Cell Lung Cancer (NSCLC) With PET/CT-Defined Target Delineation

P. Balter, R. Komaki, J. Cox, 2006 .

Guidelines and Techniques for Image-Guided Radiotherapy for Non–Small Cell Lung Cancer

Joe Y. Chang, R. Komaki, J. Cox, 2007 .

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.

S. Tucker, J. Cox, F. Cabanillas, 2003, International journal of radiation oncology, biology, physics.

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

A. Markoe, K. Russell, H. Sandler, 2000, International journal of radiation oncology, biology, physics.

Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410

W. Curran, S. Hauser, W. Sause, 2000 .

Intensity Modulated Proton Therapy for Head-and-Neck Cancer: The First Clinical Experience

R. Mohan, A. Garden, K. Ang, 2012 .

Advanced carcinoma of the nasopharynx. 2. Pattern of failure in 256 patients.

Z. Petrovich, J. Cox, R. Middleton, 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Advanced carcinoma of the nasopharynx. A clinical study of 274 patients.

Z. Petrovich, J. Cox, R. Byhardt, 1982, Radiology.

Dose-response in small cell carcinoma.

J. Cox, J. Cox, 1988, International journal of radiation oncology, biology, physics.